Haile Dagne
Subscribe to Haile Dagne's PostsIn today’s ever-changing healthcare environment, Haile helps clients tackle important market access issues, focusing on strategies to obtain coverage, coding, and appropriate payment for novel medical technologies, including medical devices, diagnostics and drugs/biologicals. He draws on his deep background analyzing regulatory and legislative policy on novel medical technologies and value-based care issues to advise on barriers and opportunities for clients across a diverse healthcare spectrum. Read Haile Dagne's full bio.
Proposed Rule on MA and Part D Would Reinstate Historical Requirements, Make Changes to Prescription Drug Payment Structure
By Kate McDonald, Mara McDermott, Ankur J. Goel, Emily Curran, Taylor Hood and Haile Dagne on Mar 3, 2022
Posted In Employee Benefits, Health and Welfare Plans
On January 6, 2022, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule regarding Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, marking the Biden administration’s first proposed rule on these topics. The proposed rule includes proposed changes to the manner in which...
Continue Reading
